DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC METHODS FOR SIMULTANEOUS ESTIMATION OF OLMESARTAN MEDOXOMIL AND INDAPAMIDE IN THEIR COMBINED TABLET DOSAGE FORM

1. Koike H, Sada T and Mizuno M: In vitro and in vivo pharmacology of olmesartan medoxomil, an angiotensin II type AT1 receptor antagonist". J Hypertens Suppl. 2001 June, http://www.drugbank.ca/drugs/DB00275
2. Dong DL, Wang QH, Yue P, Jiao JD, Gu RM and Yang BF: Indapamide induces apoptosis of GH3 pituitary cells independently of its inhibition of voltage-
dependent K+ currents. Eur J Pharmacol. 2006 Apr, http://www.drugbank.ca/drugs/DB00808
3. The Merck Index - An encyclopedia of chemicals, drugs and biological, 14th Edn; Merck Research Laboratories, 2004: pp
1152, 86.
4. The Merck Index - An encyclopedia of chemicals, drugs and biological, 14th Edn;
Available Online At www.ijprbs.com
Research Article
Khushbu Patel, IJPRBS, 2012; Volume 1(5): 485-501
Merck Research Laboratories, 2004" pp
1152, 86.
5. British Pharmacopoeia, The department of health, The Stationery office, London,
2008; 1:137.
6. Olmesartan Medoxomil-wikipedia(http://en.wikipedia.org/wiki/Olm esartanMedoximil) accesed on 15 October,
2012
7. Indapamide-wikipedia ( http://en.wikipedia.org/wiki/Indapamide) accesed on 15th oct 2012
8. Jinay Shah, Parul Parmar and Mandev Patel: Development and Validation of Spectrophotometric methods for simultaneous estimation of Amlodipine Besylate and Indapamide in combined dosage form Int J Pharm Pharm Sci, Vol 4,
Issue 3, 257-261,2012
9. Mehulkumar P, Ramesh V, Vinay kumar V, Srinivas R and Diwan PV: Simultaneous Spectroscopic Estimation of Amlodipine Besylate and Olmesartan Medoximil in Tablet Dosage Form." Asian J. Res. Chem. 2009, 2, 127-130.
ISSN: 2277-8713 IJPRBS
10. Della Grace Thomas Parambi, Dr. Sr. Molly Mathew, Anila Jose and Dr. K G Revikuma: Estimation of Olmesartan Medoxomil, an angiotensin receptor blocker in pharmaceutical dosage form by U.V. Spectrophotometric method"J. Pharm. Res. 2010; 3: 1706-1708.
11. Rote AR and Bari PD: spectrophotometric estimation of Olmesartan Medoximil and hydrochlorothiazide in tablet". Indian J.
Pharm. Sci. 2010; 1: 111-113.
12. Jain Pritam, Chaube Udit, Chaudhari Rakesh, Chaudhari Khandu, Surana Sanjay and Chaudhari Amar: Development And Validation Of UV-Spectrophotometric Method For Determination Of Olmesartan Medoxomil In Bulk And In Formulation". Internationale Pharmaceutica Sciencia.2011; 3: 54-58.
13. Kardile D.P, Kalyane N.V., Thakkar T.H., Patel M.R. and Moradiya R.K: Simultaneous estimation of Amlodipine Besylate and Olmesartan Medoxomil drug formulations by HPLC and UV-spectrophotometric methods" J. Pharm. Research .2010; 9: 599¬614.
Available Online At www.ijprbs.com
Research Article
Khushbu Patel, IJPRBS,
2012; Volume 1(5): 485-501
ISSN: 2277-8713
IJPRBS
14. Peter E. Grebow, Jo A. Treitman, Anne K. Yeung and Martha M. Johnston: Semi automated assay for indapamide in biological fluids" J.Pharma.Sci. 70(3): 235¬350.
15. Ribeiro DS, Prior JA, Santos JL, Lopes JA and Lima JL: Exploiting the oxidative coupling reaction of MBTH for indapamide determination", Talanta. J.Pharma.Sci 2009:
161-168.
16. Nadia F. Youssef: spectrophotometric, Spectrofluorimetric, And Densitometric Methods for the Determination of Indapamide"Journal of Aoac International. 2003; 89(5): 935-940.
17. Guyton and Hall: Textbook of medical physiology; 11th Edn; Elsevier - Saunders Book Company, 2005: pp 147, 216.
18. Yokoyama H, Smith RD, Averill DB and Schiffrin E: Vascular improvement with olmesartan medoxomil. Am J Hypertens
2005; 18(5): 23.
19. Brousil JA and Burke JM: Olmesartan medoxomil: an angiotensin II receptorblocker. Clin Ther 2003; 25(4): 1041.
20. Jarvis B: Olmesartan medoxomil an angiotensin II receptor blocker. Drugs2002;
62(9): 1354.
21. Chrysaqnt
SG
, Weber MA, Wang ACand Hinman DJ: Evaluation ofantihypertensive therapy with thecombination of olmesartan medoxomil and hydrochlorothiazide, Am J
Hypertens 2004; 17(3): 252.
22. Greathouse M: A review of olmesartanmedoximil monotherapy: antihypertensive efficacy similar to that of other angiotensinII receptor blocker/hydrochlorothiazide combinations. Congest Heart Fail 2002; 8(6): 3
23. Schaefer M. Sankyo Res Lab and Benica TM: Determination of olmesartan medoxomil by diazotization reaction with fluorescent compound. Annual Rep 2003;
(55): 1-91.
24. Banerji P, "Symptoms of high blood pressure", 2009, http://www.tretmentfor. com/high blood pressure symptoms.htm
25. Kalpana N. Chauhan ,Jinay Shah and Parul Parmar: Development and Validation of Spectrophotometric methods for simultaneous estimation of Amlodipine Besylate and olmesartan medoximil in
Available Online At www.ijprbs.com
Research Article ISSN: 2277-8713
Khushbu Patel, IJPRBS, 2012; Volume 1(5): 485-501 IJPRBS
combined dosage form". Research Article Pharmacy and Pharmaceutical Sciences
accepted in International Journal of (IJPPS) vol 4 suppl4/4432.pdf
Available Online